User contributions
Below you can view the list of edits made by this editor. Each edit is listed on a separate line. For help in understanding this page, see MEpedia:Contributions list.
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 14:37, October 8, 2020 (diff | hist) . . (-10) . . Endometriosis (Not potential, CDC says it is a comorbid condition) (current)
- 14:35, October 8, 2020 (diff | hist) . . (+15) . . Endometriosis (C/e) (Tag: Visual edit)
- 05:53, September 27, 2020 (diff | hist) . . (+11) . . Craniosacral therapy (C/e) (current)
- 06:22, September 26, 2020 (diff | hist) . . (+35) . . Craniosacral therapy (Cat)
- 06:18, September 26, 2020 (diff | hist) . . (+553) . . N Craniosacral therapy (Starting page copied from en-WP revision https://en.wikipedia.org/w/index.php?title=Craniosacral_therapy&oldid=977962269)
- 06:44, September 21, 2020 (diff | hist) . . (+28) . . N S4ME (Redirect) (current)
- 05:46, September 13, 2020 (diff | hist) . . (-124) . . Metabolic trap (C/e) (current) (Tag: Visual edit)
- 05:40, September 13, 2020 (diff | hist) . . (-8) . . m Metabolic trap (Not a stub, quite extensive)
- 19:34, September 12, 2020 (diff | hist) . . (+36) . . Craniocervical instability (→Outcomes, risks & complications: Add)
- 02:25, September 11, 2020 (diff | hist) . . (+53) . . Craniocervical instability (→Outcomes, risks & complications: more precise about evidence)
- 05:52, July 31, 2019 (diff | hist) . . (+1,012) . . MEpedia talk:General disclaimer (tweaks)
- 05:40, July 31, 2019 (diff | hist) . . (+39) . . MEpedia talk:General disclaimer (→MEPEDIA CAN NOT MAKE ANY GUARANTEE OF VALIDITY: proposed changes)
- 07:22, July 30, 2019 (diff | hist) . . (+1,024) . . Loratadine (more on significance in ME/CFS with ref) (Tag: Visual edit)
- 07:11, July 30, 2019 (diff | hist) . . (+173) . . N Loratadine (potential treatment)
- 06:46, July 29, 2019 (diff | hist) . . (+9) . . m Neural strain (c/e) (Tag: Visual edit)
- 03:25, July 29, 2019 (diff | hist) . . (+4) . . m Mast cell activation syndrome (→Omalizumab: link) (Tag: Visual edit)
- 03:24, July 29, 2019 (diff | hist) . . (+1,008) . . Omalizumab (more from mast cell page) (current) (Tag: Visual edit)
- 03:20, July 29, 2019 (diff | hist) . . (+391) . . Mast cell activation syndrome (→Omalizumab: ref) (Tag: Visual edit)
- 03:19, July 29, 2019 (diff | hist) . . (+561) . . Mast cell activation syndrome (→Potential Treatments: a new one)
- 07:37, July 27, 2019 (diff | hist) . . (+4) . . Christopher Larrimore (→Research: wikilink) (Tag: Visual edit)
- 07:36, July 27, 2019 (diff | hist) . . (+9) . . Christopher Larrimore (→Research: c/e, wikilinks) (Tag: Visual edit)
- 07:35, July 27, 2019 (diff | hist) . . (+40) . . Folate (cleanup template)
- 06:52, July 27, 2019 (diff | hist) . . (+304) . . Karen Schlauch (ref) (current) (Tag: Visual edit)
- 06:51, July 27, 2019 (diff | hist) . . (+1,241) . . Karen Schlauch (→Publications: ref)
- 06:51, July 27, 2019 (diff | hist) . . (+602) . . Myalgic encephalomyelitis (→Potential causes: author links)
- 06:50, July 27, 2019 (diff | hist) . . (+111) . . Genetics of chronic fatigue syndrome (→References: author links)
- 06:46, July 27, 2019 (diff | hist) . . (+1,191) . . N Karen Schlauch (relevant researcher (statistician))
- 03:20, July 27, 2019 (diff | hist) . . (+9) . . Christopher Larrimore (degrees) (Tag: Visual edit)
- 03:19, July 27, 2019 (diff | hist) . . (+1,267) . . Christopher Larrimore (→Publications: refs) (Tag: Visual edit)
- 03:15, July 27, 2019 (diff | hist) . . (+2,327) . . N Christopher Larrimore (starting entry for relevant researcher)
- 18:34, July 22, 2019 (diff | hist) . . (+443) . . Talk:Preload failure (→= Mestinon page: yes agree) (current)
- 03:06, July 22, 2019 (diff | hist) . . (+43) . . Talk:Preload failure (header)
- 03:05, July 22, 2019 (diff | hist) . . (+1,386) . . Preload failure (adding some cites, moving CN tags) (Tag: Visual edit)
- 00:53, July 21, 2019 (diff | hist) . . (+639) . . MEpedia talk:General disclaimer (→Please review and edit as needed: maybe just start with this even tho it's not totally perfect?)
- 21:07, July 20, 2019 (diff | hist) . . (0) . . m MediaWiki talk:Common.js (→Clearer disclaimer?: c/e)
- 21:07, July 20, 2019 (diff | hist) . . (-11) . . m MediaWiki talk:Common.js (→Clearer disclaimer?: c/e)
- 21:07, July 20, 2019 (diff | hist) . . (+991) . . MediaWiki talk:Common.js (→Clearer disclaimer?: reply, agree with everyone :))
- 20:42, July 20, 2019 (diff | hist) . . (+169) . . MEpedia:Suggested tasks (→Developer suggestions: awseome, thank you!)
- 02:40, July 19, 2019 (diff | hist) . . (+66) . . Acetylcholine (→Acetylcholinesterase inhibitors: c/e)
- 01:34, July 17, 2019 (diff | hist) . . (+38) . . Ehlers-Danlos syndrome (→Comorbidities & complications: c/e) (Tag: Visual edit)
- 01:31, July 17, 2019 (diff | hist) . . (+5) . . m Collagen (→Infection and Ehlers-Danlos Syndrome: minor c/e) (Tag: Visual edit)
- 18:29, July 16, 2019 (diff | hist) . . (+315) . . MEpedia:Suggested tasks (→Developer suggestions: request)
- 18:20, July 16, 2019 (diff | hist) . . (-12) . . Acetylcholine (Undo revision 61825 by Canele (talk) actually I'm not really prepared to read these studies right now)
- 18:17, July 16, 2019 (diff | hist) . . (+12) . . Acetylcholine (→In human disease: alphabetizing, adding autism section)
- 01:34, July 14, 2019 (diff | hist) . . (+1,110) . . MEpedia talk:Science guidelines (on sources)
- 01:17, July 14, 2019 (diff | hist) . . (-2) . . m MEpedia:Science guidelines (→Suggested Sources: correcting formatting)
- 02:33, July 12, 2019 (diff | hist) . . (+825) . . Talk:Machine Learning-Guided ME/CFS Research (agree)
- 16:49, July 10, 2019 (diff | hist) . . (+8) . . m Prevalence of myalgic encephalomyelitis and chronic fatigue syndrome (→Notable studies: formatting) (current)
- 16:47, July 10, 2019 (diff | hist) . . (+114) . . Prevalence of myalgic encephalomyelitis and chronic fatigue syndrome (→Notable studies: adding remaining authors)
- 03:58, July 10, 2019 (diff | hist) . . (+22) . . User:Canele (update) (current) (Tag: Visual edit)
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
